Cancer Treatment Timing May Affect Survival and Toxicity

Circadian Clocks and Cancer Care

New research presented this week suggests that the time of day when cancer patients receive treatment might influence both survival rates and the severity of side effects. The findings, reported by EMJ, add to a growing body of evidence that our body's internal clock, or circadian rhythm, plays a role in how well therapies work.

The study, which has not yet been published in a peer-reviewed journal, examined data from patients undergoing various cancer treatments. Researchers found a noticeable difference in outcomes depending on whether therapy was administered in the morning or later in the day.

Key Observations from the Data

While the full dataset has not been made public, the researchers highlighted two main trends. First, patients who received certain drugs in the afternoon showed better overall survival compared to those treated in the early hours. Second, the timing also appeared to affect toxicity—patients treated at specific times reported fewer severe side effects.

These observations are preliminary, and the underlying mechanisms remain unclear. However, scientists believe that circadian rhythms influence cell division, DNA repair, and drug metabolism, all of which could alter how a cancer cell responds to treatment.

What This Could Mean for Patients

If confirmed, this could lead to a shift in how oncology departments schedule infusions and radiation sessions. Instead of a one-size-fits-all timetable, doctors might tailor treatment times to each patient's biological profile.

Such an approach, known as chronotherapy, has been explored for decades but has not yet entered mainstream practice. The new findings could give it fresh momentum, though experts caution that much more work is needed.

Expert Reactions and Cautions

Several oncologists have welcomed the research but stressed that it is too early to change clinical guidelines. Dr. Meera Krishnan, a medical oncologist based in Mumbai, told TIVRA News, "The concept is biologically plausible, but we need large, randomised trials to confirm that timing alone can improve outcomes."

She added, "We don't want patients to delay or reschedule their treatments based on preliminary data. That could be dangerous." Other experts have echoed this, noting that the study's methodology has not been fully scrutinised.

Looking Ahead

The research team plans to conduct a larger prospective study to validate these findings. If successful, hospitals may eventually adopt time-based scheduling as a standard part of cancer care.

For now, patients are advised to continue with their prescribed treatment plans. The hope is that one day, a simple change in the clock could make a significant difference in the fight against cancer.